The role of regularity and synchrony of cerebellar Purkinje cells for pathological nystagmus

Previous theories assumed that the beneficial effect of the potassium channel blocker 4‐aminopyridine (4‐AP) for patients suffering from downbeat nystagmus (DBN) or episodic ataxia type 2 (EA2) is due to an increase of excitability of cerebellar Purkinje cells (PC). Recent experimental results using therapeutic doses of 4‐AP with a mouse model of EA2 challenged the theory showing that 4‐AP does not change the firing rate of PC but their regularity. Based on a mathematical model of the ocular motor and cerebellar circuitry, we show that changes in regularity have no effect without synchrony in PC firing. Together with synchronous firing, an increase in regularity may lead to a decrease in overall inhibition and may invert the inhibitory to an excitatory response due to imprinting, a novel effect of synchronized neural inhibition. Both effects are unlikely to be the causative mechanism for the success of 4‐AP in treating cerebellar disorders.

[1]  U Büttner,et al.  Three-dimensional eye position and slow phase velocity in humans with downbeat nystagmus. , 2003, Journal of neurophysiology.

[2]  A. Mcguire,et al.  What is it to be a model? , 2000, HEPAC Health Economics in Prevention and Care.

[3]  Susan L. Wearne,et al.  The role of action potential shape and parameter constraints in optimization of compartment models , 2006, Neurocomputing.

[4]  Stefan Glasauer,et al.  The Origin of Downbeat Nystagmus: An Asymmetry in the Distribution of On‐Directions of Vertical Gaze‐Velocity Purkinje Cells , 2005, Annals of the New York Academy of Sciences.

[5]  Y. Yarom,et al.  Jittery trains induced by synaptic-like currents in cerebellar inhibitory interneurons. , 2002, Journal of neurophysiology.

[6]  R. Morris.  Foundations of cellular neurophysiology , 1996 .

[7]  Dilwyn E Marple-Horvat,et al.  Mechanisms of synchronous activity in cerebellar Purkinje cells , 2010, The Journal of physiology.

[8]  R. Baloh,et al.  Primary episodic ataxias: diagnosis, pathogenesis and treatment. , 2007, Brain : a journal of neurology.

[9]  Pierre-Paul Vidal,et al.  Intrinsic membrane properties and dynamics of medial vestibular neurons: a simulation , 1999, Biological Cybernetics.

[10]  T. Brandt,et al.  Downbeat nystagmus: aetiology and comorbidity in 117 patients , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  C. Weisz,et al.  Potassium Channel Blockers Inhibit the Triggers of Attacks in the Calcium Channel Mouse Mutant tottering , 2005, The Journal of Neuroscience.

[12]  S Glasauer,et al.  Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine , 2004, Neurology.

[13]  T. Brandt,et al.  4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. , 2007, Brain : a journal of neurology.

[14]  T. Sejnowski,et al.  Fluctuating synaptic conductances recreate in vivo-like activity in neocortical neurons , 2001, Neuroscience.

[15]  Erik De Schutter,et al.  Synchronization of Purkinje Cell Pairs Along the Parallel Fiber Axis: A Modeling Study , 2002, Neurocomputing.

[16]  Kamran Khodakhah,et al.  The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar Ataxia , 2010, The Journal of Neuroscience.

[17]  Modelling drug modulation of nystagmus. , 2008, Progress in brain research.

[18]  S. Glasauer,et al.  A model-based theory on the origin of downbeat nystagmus , 2008, Experimental Brain Research.

[19]  T. Sejnowski,et al.  Synchrony of Thalamocortical Inputs Maximizes Cortical Reliability , 2010, Science.

[20]  I. Soltesz,et al.  Modulation of network behaviour by changes in variance in interneuronal properties , 2002, The Journal of physiology.

[21]  Peter Dayan,et al.  Theoretical Neuroscience: Computational and Mathematical Modeling of Neural Systems , 2001 .

[22]  Michael L. Hines,et al.  The NEURON Book , 2006 .

[23]  Eberhard E. Fetz,et al.  Effects of Input Synchrony on the Firing Rate of a Three-Conductance Cortical Neuron Model , 1994, Neural Computation.

[24]  T. Brandt,et al.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias , 2011, Neurology.

[25]  U Büttner,et al.  Treatment of downbeat nystagmus with 3,4-diaminopyridine , 2003, Neurology.